A novel nanocomposite drug delivery system for SARS-CoV-2 infections-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel nanocomposite drug delivery system for SARS-CoV-2 infections

Published:2024 Issue:15 Volume:6 Page:3747-3758
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Chintapula Uday¹,Karim Shazeed-Ul²,Iyer Priyanka Raghunathan¹,Asokan-Sheeja Haritha³,Neupane Biswas²,Nazneen Farzana²^ORCID,Dong He³^ORCID,Bai Fengwei²,Nguyen Kytai T.¹

Affiliation:

1. Department of Bioengineering, University of Texas at Arlington, Arlington, TX 76010, USA

2. Department of Cell and Molecular Biology, University of Southern Mississippi, Hattiesburg, MS 39406, USA

3. Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76010, USA

Abstract

To develop an inhalable drug delivery system, we synthesized Remdesivir-loaded nanocomposites (RDV NCs) by coating drug-loaded nanoparticles with supramolecular cell-penetrating peptide nanofibers, enhancing uptake and intracellular drug delivery.

Funder

National Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/NA/D4NA00361F

Reference58 articles.

1. Organization WH , COVID-19 statistics worldwide , 2020 , Accessed May 27, https://covid19.who.int/

2. Diabetes is a risk factor for the progression and prognosis of COVID ‐19

3. SARS-CoV-2 and diabetes: New challenges for the disease

4. Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?

5. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP